Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

P G Casali; S Bielack; N Abecassis; H T Aro; S Bauer; R Biagini; S Bonvalot; I Boukovinas; J V M G Bovee; B Brennan; T Brodowicz; J M Broto; L Brugières; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; P Dileo; C Dhooge; M Eriksson; F Fagioli; A Fedenko; V Ferraresi; A Ferrari; S Ferrari; A M Frezza; N Gaspar; S Gasperoni; H Gelderblom; T Gil; G Grignani; A Gronchi; R L Haas; B Hassan; S Hecker-Nolting; P Hohenberger; R Issels; H Joensuu; R L Jones; I Judson; P Jutte; S Kaal; L Kager; B Kasper; K Kopeckova; D A Krákorová; R Ladenstein; A Le Cesne; I Lugowska; O Merimsky; M Montemurro; B Morland; M A Pantaleo; R Piana; P Picci; S Piperno-Neumann; A L Pousa; P Reichardt; M H Robinson; P Rutkowski; A A Safwat; P Schöffski; S Sleijfer; S Stacchiotti; S J Strauss; K Sundby Hall; M Unk; F Van Coevorden; W T A van der Graaf; J Whelan; E Wardelmann; O Zaikova; J Y Blay; ESMO Guidelines Committee, PaedCan and ERN EURACAN

doi:10.1093/annonc/mdy310

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95. doi: 10.1093/annonc/mdy310.

Authors

P G Casali¹, S Bielack², N Abecassis³, H T Aro⁴, S Bauer⁵, R Biagini⁶, S Bonvalot⁷, I Boukovinas⁸, J V M G Bovee⁹, B Brennan¹⁰, T Brodowicz¹¹, J M Broto¹², L Brugières¹³, A Buonadonna¹⁴, E De Álava¹⁵, A P Dei Tos¹⁶, X G Del Muro¹⁷, P Dileo¹⁸, C Dhooge¹⁹, M Eriksson²⁰, F Fagioli²¹, A Fedenko²², V Ferraresi⁶, A Ferrari²³, S Ferrari²⁴, A M Frezza²⁵, N Gaspar¹³, S Gasperoni²⁶, H Gelderblom²⁷, T Gil²⁸, G Grignani²⁹, A Gronchi¹, R L Haas³⁰, B Hassan³¹, S Hecker-Nolting², P Hohenberger³², R Issels³³, H Joensuu³⁴, R L Jones³⁵, I Judson³⁶, P Jutte³⁷, S Kaal³⁸, L Kager³⁹, B Kasper³², K Kopeckova⁴⁰, D A Krákorová⁴¹, R Ladenstein³⁹, A Le Cesne¹³, I Lugowska⁴², O Merimsky⁴³, M Montemurro⁴⁴, B Morland⁴⁵, M A Pantaleo⁴⁶, R Piana²¹, P Picci²⁴, S Piperno-Neumann⁷, A L Pousa⁴⁷, P Reichardt⁴⁸, M H Robinson⁴⁹, P Rutkowski⁴², A A Safwat⁵⁰, P Schöffski⁵¹, S Sleijfer⁵², S Stacchiotti²⁵, S J Strauss¹⁸, K Sundby Hall⁵³, M Unk⁵⁴, F Van Coevorden⁵⁵, W T A van der Graaf^{35

38

55}, J Whelan¹⁸, E Wardelmann⁵⁶, O Zaikova⁵⁷, J Y Blay⁵⁸; ESMO Guidelines Committee, PaedCan and ERN EURACAN

Affiliations

¹ Fondazione IRCCS Istituto Nazionale dei Tumori, Milan and University of Milan, Milan, Italy.
² Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
³ Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal.
⁴ Turku University Hospital (Turun Yliopistollinen Keskussairaala), Turlu, Finland.
⁵ University Hospital Essen, Essen, Germany.
⁶ Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy.
⁷ Institut Curie, Paris, France.
⁸ Bioclinic Thessaloniki, Thessaloniki, Greece.
⁹ Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
¹⁰ Royal Manchester Children's Hospital, Manchester, UK.
¹¹ Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria.
¹² Hospital Universitario Virgen del Rocio-CIBERONC, Seville, Spain.
¹³ Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Centro di Riferimento Oncologico di Aviano, Aviano.
¹⁵ Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital /CSIC/University of Sevilla/CIBERONC, Seville, Spain.
¹⁶ Ospedale Regionale di Treviso "S.Maria di Cà Foncello", Treviso, Italy.
¹⁷ Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain.
¹⁸ Sarcoma Unit, University College London Hospitals NHS Trust, London, UK.
¹⁹ Ghent University Hospital (Pediatric Hematology-Oncology & Stem Cell Transplantation), Ghent, Belgium.
²⁰ Skane University Hospital-Lund, Lund, Sweden.
²¹ Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
²² N. N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.
²³ Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
²⁴ Istituto Ortopedico Rizzoli, Bologna.
²⁵ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy.
²⁶ Azienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
²⁷ Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
²⁸ Institut Jules Bordet, Brussels, Belgium.
²⁹ Candiolo Cancer Institute, FPO IRCCS, Candiolo, Italy.
³⁰ Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam and Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands.
³¹ Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
³² Mannheim University Medical Center, Mannheim.
³³ Department of Medicine III, University Hospital Ludwig-Maximilians-University Munich, Munich, Germany.
³⁴ Helsinki University Central Hospital (HUCH), Helsinki, Finland.
³⁵ Royal Marsden Hospital, London.
³⁶ The Institute of Cancer Research, London, UK.
³⁷ University Medical Center Groningen, Groningen.
³⁸ Radboud University Medical Center, Nijmegen, The Netherlands.
³⁹ St. Anna Children's Hospital & Children's Cancer Research Institute, Medical University Vienna, Vienna, Austria.
⁴⁰ University Hospital Motol, Prague.
⁴¹ Masaryk Memorial Cancer Institute, Brno, Czech Republic.
⁴² Maria Sklodowska Curie Institute-Oncology Centre, Warsaw, Poland.
⁴³ Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel.
⁴⁴ Medical Oncology University Hospital of Lausanne, Lausanne, Switzerland.
⁴⁵ Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
⁴⁶ Azienda Ospedaliera, Universitaria, Policlinico S Orsola-Malpighi Università di Bologna, Bologna, Italy.
⁴⁷ Fundacio de Gestio Sanitaria de L'Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
⁴⁸ Helios Klinikum Berlin Buch, Berlin, Germany.
⁴⁹ YCRC Department of Clinical Oncology, Weston Park Hospital NHS Trust, Sheffield, UK.
⁵⁰ Aarhus University Hospital, Aarhus, Finland.
⁵¹ Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
⁵² Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁵³ Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
⁵⁴ Institute of Oncology of Ljubljana, Ljubljana, Slovenia.
⁵⁵ Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
⁵⁶ Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Münster, Germany.
⁵⁷ Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
⁵⁸ Centre Leon Bernard and UCBL1, Lyon, France.

PMID: 30285218
DOI: 10.1093/annonc/mdy310

No abstract available

Publication types

Practice Guideline

MeSH terms

Adult
Aftercare / methods
Aftercare / standards
Age Factors
Antineoplastic Combined Chemotherapy Protocols / standards
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Bone Neoplasms / diagnosis
Bone Neoplasms / epidemiology
Bone Neoplasms / pathology
Bone Neoplasms / therapy*
Bone and Bones / diagnostic imaging
Bone and Bones / pathology
Bone and Bones / surgery
Child
Europe
Humans
Incidence
Long-Term Care / methods
Long-Term Care / standards
Magnetic Resonance Imaging
Medical Oncology / methods
Medical Oncology / standards*
Neoadjuvant Therapy / methods
Neoadjuvant Therapy / standards
Neoplasm Staging
Orthopedic Procedures / methods
Orthopedic Procedures / standards
Osteosarcoma / diagnosis
Osteosarcoma / epidemiology
Osteosarcoma / pathology
Osteosarcoma / therapy*
Patient Participation*
Positron Emission Tomography Computed Tomography
Radionuclide Imaging
Radiotherapy, Adjuvant / methods
Radiotherapy, Adjuvant / standards
Self-Help Groups / standards
Societies, Medical / standards
Survivorship
Treatment Outcome